MRI in Staging Ovarian Cancer Using MRI Contrast Agent
Sponsor
University of Aarhus (Other)
Overall Status
Unknown status
CT.gov ID
NCT00463996
Collaborator
(none)
50
12
Study Details
Study Description
Brief Summary
Can MRI be used to stage ovarian cancer?
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Detailed Description
Staging of ovarian cancer can best be performed with CT or MRI compared to ultrasound. Studies have shown an increase in pos. predictive value by adding contrast i.v. to the MR-examination protocol. We compare staging of ovarian cancer by 1.MRI without contrast (standard method) to 2.MRI with contrast agent i.v. (new method)in the same patient. Golden standard are findings at operation.
Study Design
Study Type:
Observational
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Værdien af MRI Til Staging af c.Ovarii-et Prospektivt Studie
Study Start Date
:
Apr 1, 2007
Anticipated Study Completion Date
:
Apr 1, 2008
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- suspicion of ovarian cancer
Exclusion Criteria:
-
recurrence of disease
-
contraindication to MRI, contrast agent
-
inoperable patients for other reasons
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University of Aarhus
Investigators
- Principal Investigator: Liselotte Ibsen, doc, Aarhus University Hospital, BDA, Skejby
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00463996
Other Study ID Numbers:
- MR-Center-001
First Posted:
Apr 20, 2007
Last Update Posted:
Apr 20, 2007
Last Verified:
Apr 1, 2007
Keywords provided by ,
,
Additional relevant MeSH terms: